Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from Yidu Tech, Inc. ( (HK:2158) ).
Yidu Tech Inc. said its affiliate Yidu Cloud (Beijing) Technology Co., Ltd. has won a bid to build the Phase II Provincial Coordinated Regional Infectious Disease Monitoring, Warning and Emergency Command Information Platform in Hainan Province, a project worth about RMB12.89 million. The contract strengthens Yidu Tech’s role in China’s public health infrastructure, showcasing its AI-driven capabilities in disease monitoring and emergency response while reinforcing its positioning as a key enabler of intelligent, resilient healthcare systems.
The company describes itself as a core driver of intelligent healthcare upgrading in China, applying AI that “understands diseases” to empower doctors with better decision tools and to support pharmaceutical development, insurers and public health agencies. By offering precision diagnostics, treatment support and systematic public health intelligence, Yidu Tech aims to make precision healthcare more accessible, bolster healthcare system resilience and deepen its integration across the healthcare value chain.
More about Yidu Tech, Inc.
Yidu Tech Inc. is a Chinese healthcare technology company focused on using artificial intelligence to upgrade the national healthcare system. Its platforms support healthcare services, pharmaceuticals, insurance and patients by simulating clinical decision-making, improving diagnostic and treatment precision, and providing data-driven tools for public health management.
Average Trading Volume: 7,920,686
Technical Sentiment Signal: Sell
Current Market Cap: HK$5.79B
For detailed information about 2158 stock, go to TipRanks’ Stock Analysis page.